Literature DB >> 2763804

Human oligodendrocytes in dissociated cell culture.

F Rihs1, J Kesselring, C Meier.   

Abstract

Human oligodendrocytes have been successfully maintained in cell cultures for 14 weeks using a modification of a method used previously for animal brain cell cultures. Dissociated cell cultures from spinal cords of human foetuses of 10 to 20 weeks gestional age were investigated for up to 98 days. Oligodendrocytes were identified by monoclonal human antiserum specific for myelin-associated glycoprotein, by polyclonal rabbit antiserum against myelin basic protein, and by the mouse monoclonal antibody I6G1. Astrocytes were identified by polyclonal antibodies against glial fibrillary acidic protein. Immunocytochemical cell identification was corroborated by electron microscopy, by which glial cells were investigated both in situ and in culture. Immunocytochemical staining of myelin-associated glycoprotein showed specifically labelled oligodendrocytes on electron microscopy. The present study indicates that human oligodendrocytes, a putative target in demyelinating disease, can be studied in dissociated cell culture of human foetal spinal cord for several weeks in vitro under stable conditions.

Entities:  

Mesh:

Year:  1989        PMID: 2763804     DOI: 10.1007/BF00687762

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  28 in total

Review 1.  Oligodendrocytes, key cells in myelination and target in demyelinating diseases.

Authors:  L Bologa
Journal:  J Neurosci Res       Date:  1985       Impact factor: 4.164

2.  Long-term culture of human oligodendrocytes. Isolation, growth and identification.

Authors:  S U Kim; Y Sato; D H Silberberg; D E Pleasure; L B Rorke
Journal:  J Neurol Sci       Date:  1983-12       Impact factor: 3.181

3.  Neural cell adhesion molecules and myelin-associated glycoprotein share a common carbohydrate moiety recognized by monoclonal antibodies L2 and HNK-1.

Authors:  J Kruse; R Mailhammer; H Wernecke; A Faissner; I Sommer; C Goridis; M Schachner
Journal:  Nature       Date:  1984 Sep 13-19       Impact factor: 49.962

4.  Glia cell stimulating factor (GSF): a new lymphokine. Part 1. Cellular sources and partial purification of murine GSF, role of cytoskeleton and protein synthesis in its production.

Authors:  A Fontana; R Dubs; R Merchant; S Balsiger; P J Grob
Journal:  J Neuroimmunol       Date:  1982-01       Impact factor: 3.478

5.  Myelin-associated glycoprotein demonstrated immunocytochemically in myelin and myelin-forming cells of developing rat.

Authors:  N H Sternberger; R H Quarles; Y Itoyama; H D Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

6.  Growth of human oligodendrocytes in vitro on extracellular matrix.

Authors:  I Korn-Lubetzki; H Ovadia; U Wald; O Abramsky
Journal:  Neurosci Lett       Date:  1986-08-15       Impact factor: 3.046

7.  Requirement for nonoligodendrocyte cell signals for enhanced myelinogenic gene expression in long-term cultures of purified rat oligodendrocytes.

Authors:  S Bhat; E Barbarese; S E Pfeiffer
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

8.  Serum contains inducers and repressors of oligodendrocyte differentiation.

Authors:  L Bologa; R Cole; F Chiappelli; R P Saneto; J de Vellis
Journal:  J Neurosci Res       Date:  1988       Impact factor: 4.164

9.  Specific antibody activity against neuroendocrine tissue in a case of POEMS syndrome with IgG gammopathy.

Authors:  M Reulecke; M Dumas; C Meier
Journal:  Neurology       Date:  1988-04       Impact factor: 9.910

10.  Myelin-associated glycoprotein is produced before myelin basic protein in cultured oligodendrocytes.

Authors:  A Zurbriggen; M Vandevelde; A Steck; B Angst
Journal:  J Neuroimmunol       Date:  1984-02       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.